Literature DB >> 21831793

Bifidobacterium breve - HT-29 cell line interaction: modulation of TNF-α induced gene expression.

R J Boesten1, F H J Schuren, L E M Willemsen, A Vriesema, J Knol, W M De Vos.   

Abstract

To provide insight in the molecular basis for intestinal host-microbe interactions, we determined the genome-wide transcriptional response of human intestinal epithelial cells following exposure to cells of Bifidobacterium breve. To select an appropriate test system reflecting inflammatory conditions, the responsiveness to TNF-α was compared in T84, Caco-2 and HT-29 cells. The highest TNF-α response was observed in HT-29 cells and this cell line was selected for exposure to the B. breve strains M-16V, NR246 and UCC2003. After one hour of bacterial pre-incubation followed by two hours of additional TNF-α stimulation, B. breve M-16V (86%), but to a much lesser extent strains NR246 (50%) or UCC2003 (32%), showed a strain-specific reduction of the HT-29 transcriptional response to the inflammatory treatment. The most important functional groups of genes that were transcriptionally suppressed by the presence of B. breve M-16V, were found to be involved in immune regulation and apoptotic processes. About 54% of the TNF-α induced genes were solely suppressed by the presence of B. breve M-16V. These included apoptosis-related cysteine protease caspase 7 (CASP7), interferon regulatory factor 3 (IRF3), amyloid beta (A4) precursor proteinbinding family A member 1 (APBA1), NADPH oxidase (NOX5), and leukemia inhibitory factor receptor (LIFR). The extracellular IL-8 concentration was determined by an immunological assay but did not change significantly, indicating that B. breve M-16V only partially modulates the TNF-α pathway. In conclusion, this study shows that B. breve strains modulate gene expression in HT-29 cells under inflammatory conditions in a strain-specific way.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21831793     DOI: 10.3920/BM2011.0005

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  6 in total

1.  Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function.

Authors:  Maciej Chichlowski; Guillaume De Lartigue; J Bruce German; Helen E Raybould; David A Mills
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-09       Impact factor: 2.839

Review 2.  Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.

Authors:  Julio Plaza-Diaz; Carolina Gomez-Llorente; Luis Fontana; Angel Gil
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

3.  Probiotics and Innate and Adaptive Immune Responses in Premature Infants.

Authors:  Mark A Underwood
Journal:  For Immunopathol Dis Therap       Date:  2016

Review 4.  Role of lung and gut microbiota on lung cancer pathogenesis.

Authors:  Yue Zhao; Yuxia Liu; Shuang Li; Zhaoyun Peng; Xiantao Liu; Jun Chen; Xin Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2021-05-20       Impact factor: 4.553

5.  A Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates Partial Non-Responsiveness to Whey Protein in Mice Orally Exposed to β-Lactoglobulin-Derived Peptides.

Authors:  Atanaska I Kostadinova; Laura A P M Meulenbroek; Betty C A M van Esch; Gerard A Hofman; Johan Garssen; Linette E M Willemsen; Léon M J Knippels
Journal:  Front Immunol       Date:  2017-01-12       Impact factor: 7.561

6.  Dysbiosis of the Gut Microbiome in Lung Cancer.

Authors:  He Zhuang; Liang Cheng; Yao Wang; Yu-Kun Zhang; Man-Fei Zhao; Gong-Da Liang; Meng-Chun Zhang; Yong-Guo Li; Jing-Bo Zhao; Yi-Na Gao; Yu-Jie Zhou; Shu-Lin Liu
Journal:  Front Cell Infect Microbiol       Date:  2019-04-18       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.